Caiola, Elisa <br/><br/>
Different metabolic responses to PI3K inhibition in NSCLC cells harboring wild-type and G12C mutant KRAS.  [electronic resource] 

 -  Oncotarget  Aug 2016 
 - 51462-51472 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.9849  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amino Acid Substitution<br/>Carcinoma, Non-Small-Cell Lung--genetics<br/>Cells, Cultured<br/>Cysteine--genetics<br/>Glycine--genetics<br/>Humans<br/>Imidazoles--pharmacology<br/>Lung Neoplasms--genetics<br/>Mutation, Missense<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins p21(ras)--genetics<br/>Quinolines--pharmacology<br/>Signal Transduction--drug effects